| Description | This product is a broadly neutralizing antibody against ZIKV and DENV. MZ24 mAb exhibits high potency in neutralizing both ZIKV and DENV-2, with IC₅₀ values of 166.4 ng/mL and 12.4 ng/mL, respectively. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Zika Virus (ZIKV), Dengue Virus (DENV) |
| Cross Reactivity | DENV2 |
| Immunogen | ZIKV purified inactivated vaccine |
| IC50 | 166.4 ng/mL (ZIKV) 12.4 ng/mL (DENV-2) |
| Isotype | Human IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | ELISA; Neut |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | ZIKV / DENV |
| Alternative Name | ZIKV; DENV; Zika virus; Dengue virus; Envelope; E |
| Research Area | Microbiology |
